vimarsana.com

Latest Breaking News On - Chromiumx series - Page 1 : vimarsana.com

10x Genomics, Inc Share Price Target $58 50 , now 21 7% Upside Potential

10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology

GEM-X, the next generation of the company s leading single cell technology architecture, enables higher performance at larger scale and lower cost Pre-orders now open for first two Chromium products.

10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.